MedTrace Logo

Natural History Study for Achromatopsia

NCT04124185 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 85

Last updated 2023-06-27

No results posted yet for this study

Summary

In preparation for human clinical trials we intend to undertake a detailed phenotypic study to help to identify patients who may be suitable for therapeutic intervention. In addition, with the recent availability of advanced imaging modalities, further detailed phenotypic investigations will also be valuable in helping to probe the relationship between structure and function and may shed light on disease mechanisms.

Conditions

  • Achromatopsia

Interventions

DIAGNOSTIC_TEST

Ocular assessments

Complete ocular examination, Axial length and corneal curvature, Optical Coherence Tomography, Visual acuity, Contrast sensitivity

Sponsors & Collaborators

  • MeiraGTx UK II Ltd

    lead INDUSTRY

Eligibility

Min Age
3 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-13
Primary Completion
2023-05-18
Completion
2023-05-18

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04124185 on ClinicalTrials.gov